Core Insights - Institutional adoption of crypto has gained momentum following the U.S. approval of spot Bitcoin ETFs in January 2024, leading to discussions on asset allocation strategies [1] - The debate centers around whether large investors should allocate more than 5% of their assets under management to crypto, with allocations above the pre-2025 standard risk-adjusted threshold of 1-5% seen as a significant win for Bitcoin [1] Group 1: Institutional Behavior - Institutions are increasingly considering allocations above the 5% threshold due to a mix of structural factors such as ETFs, custody solutions, and evolving accounting standards, alongside market sentiment [2] - The competitive fear of missing out (FOMO) is driving this shift, as no Chief Investment Officer (CIO) wants to be left behind by peers [3] Group 2: Diversification and Risk - While crypto assets may show high correlation with equities during downturns, they are still viewed as a means to diversify return streams over the long term, with allocations beyond 5% focusing on capturing uncorrelated sources of long-term alpha [4] - Critics argue that institutions may confuse speculative growth potential with sustainable long-term value, but the current investment landscape includes regulated ETFs and infrastructure developments that support long-term market evolution [5] Group 3: Market Dynamics - The return distributions of crypto assets differ from traditional assets, influenced by factors such as adoption cycles, technological innovation, and monetary dynamics [6] - Institutions are exploring tactical flexibility through yield strategies, lending, and derivatives, indicating a more sophisticated approach to crypto investments [6]

Core Viewpoint - Investors are increasingly turning to gold as a safe haven, with projections suggesting prices could reach $4,000 per ounce by mid-2026, driven by macroeconomic factors and strong demand [1][2]. Gold Price Projections - Goldman Sachs has revised its gold price forecast, now seeing a potential rise to $4,000 per ounce, with a 75% probability of this occurring within the next few months [2]. - The outlook suggests that gold could reach $5,000 per ounce rather than $3,000 in the next 6 to 12 months, despite potential seasonal retrenchment in November and December [3]. Market Dynamics - The current rally in gold prices is supported by a weaker dollar, strong physical demand from China, and record inflows into gold ETFs, particularly over $10 billion in September [5][6]. - Gold was previously underowned, but investor interest has surged in the last 3 to 6 months due to rising uncertainty around inflation and Federal Reserve policies [7]. Investment Strategies - For gaining exposure to gold, ETFs are recommended over physical gold due to lower transaction costs and higher liquidity. State Street Investment Management's Spider ETF suite is highlighted as a leading option [9]. - Gold mining stocks have outperformed gold this year, but they are not seen as a reliable substitute for direct gold exposure due to their inherent risks and management dependencies [10][11]. Other Precious Metals - Silver has been identified as a catch-up trade, with potential to reach $50 per ounce if gold surpasses $4,000. However, silver's performance is closely tied to industrial activity [12][13]. - The current geopolitical and economic uncertainties suggest that gold will maintain its status as a safe haven, while silver may lag behind in the event of stagflation or recession [15][16].

Core Insights - Chilton Capital Management's REIT Team is led by experienced co-portfolio managers Bruce Garrison and Matt Werner, focusing on publicly traded real estate investment trusts (REITs) and related entities primarily in North America [1] - The REIT Team believes that public REITs offer superior investment vehicles due to their liquidity, transparency, and total return characteristics, allowing for diversified investments across various geographies, sectors, and property types [1] - The investment strategy combines real estate industry experience with traditional security analysis methods, emphasizing research and analytical depth to make informed investment decisions [1] Company Overview - Chilton Capital Management is an independently owned firm established in 1996, providing investment advisory services to a range of clients including registered investment companies, private clients, family offices, endowments, foundations, retirement plans, and trusts [1] - The REIT Team manages Separately Managed Accounts (SMAs) for high net worth individuals and institutions, and serves as a sub-advisor for the West Loop Realty Fund [1] Investment Focus - The REIT Team's investment focus includes various property types such as apartments, regional malls, shopping centers, lodging, office, industrial, self-storage, data centers/cell towers, and healthcare-related facilities [1] - The investment approach aims to leverage both real estate expertise and traditional security selection methods to optimize investment outcomes in real estate companies [1]

Core Insights - Blue Owl Capital Corporation (OBDC) is positioned strongly due to portfolio diversification, increasing investment income, and disciplined capital deployment [1] - The company closed Q2 with a portfolio valued at $16.9 billion across 233 portfolio companies [1] Growth Drivers for OBDC - Turbulent market conditions are creating opportunities in direct lending, focusing on first-lien, senior secured loans, and select private equity investments, which enhances diversification and reduces single-borrower risk [2] - Total investment income for the first half of 2025 increased by 19.4% year over year to $950.5 million, with net investment margins showing a gradual decline: 47.6% in 2023, 46.4% in 2024, and 44% in the first half of 2025 [2] Cash Flow Trends - Net operating cash flow reached $1.1 billion in the first half of 2025, a significant improvement from a net cash usage of $282.2 million a year earlier [3] - Free cash flow after dividends surged to approximately $751 million over the past 12 months [3] Shareholder Rewards - OBDC prioritizes shareholder rewards, offering a dividend yield above the industry average, complemented by quarterly extras [4] - In Q2, investors received a regular payout of 37 cents per share along with a 2-cent supplemental dividend [4] Earnings Performance - OBDC's earnings have surpassed the Zacks Consensus Estimate in one of the last four quarters, meeting expectations once and missing twice, with an average surprise of negative 2.2% [5] Key Concerns - OBDC has $9.2 billion in long-term debt against $359.5 million in cash and restricted cash as of June 30, 2025, with a long-term debt-to-capital ratio of 54.6%, higher than the industry average of 45.2% [6] - Return on capital is at 5%, below the industry average of 7.3%, indicating weaker efficiency in utilizing shareholder funds [6] Peer Performance - Competitors like Ares Capital Corporation (ARCC) and FS KKR Capital Corp. (FSK) are also active in the market [7] - Ares Capital originated $6.1 billion in gross investment commitments in the first half of 2025, although rising expenses are a concern [7] - FS KKR Capital, with a diversified portfolio of 218 companies across 23 industries, generated $398 million in total investment income in Q2 [8]

Joining me now, Brett Sheileely, head of ETF specialists at Alliance Bernstein. Brett, thanks so much for joining me at the desk. >> Thank you for having me today.>> So, we have seen really impressive returns from US stocks. Fourth quarter is historically the strongest quarter >> of the year and you're telling us that we should be investing internationally. Make the case.Why should we be putting money abroad. >> Well, you know, it's been a really strong year for US stocks. It's also been a very strong year ...

Core Insights - The logistics sector has seen significant engagement from investors, particularly in the ASEAN and US markets, highlighting its growth potential and diversification opportunities [1] - The popularity of insurance companies in the Philippines since 2014 has influenced investment strategies, leading to a broader portfolio that includes various industries and market capitalizations [1] - The entry into the US market in 2020 has allowed for comparative analysis between US and ASEAN markets, particularly in sectors like banking, hotels, and logistics [1] Investment Strategies - Initial investments were focused on blue-chip companies, but the strategy has evolved to include a mix of retirement holdings and trading profits across different sectors [1] - The encouragement to diversify investments beyond traditional savings in banks and properties has led to a more dynamic investment approach [1] - The use of platforms like Seeking Alpha has facilitated knowledge sharing and enhanced market awareness, particularly for newer investors in the US market [1] Market Trends - The logistics and shipping industries are highlighted as key areas of investment, reflecting their importance in both the ASEAN and US markets [1] - The banking and telecommunications sectors remain focal points for investment, indicating their stability and growth potential in the current economic landscape [1] - The trend of engaging in stock markets as a means of portfolio diversification is becoming increasingly popular among investors in the Philippines [1]

I have been working in the logistics sector for almost two decades. I have been into stock investing and macroeconomic analysis for almost a decade. Currently, I focus on ASEAN and NYSE/NASDAQ Stocks, particularly in banks, telco, logistics, and hotels. Since 2014, I have been trading on the PH stock market. I focus on banking, telco, and retail sectors. A colleague encouraged me to engage in the stock market as part of my portfolio diversification instead of putting all my savings in banks and properties. ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Anthony Scaramucci is seemingly mixing business with humor, sharing a workout video with Arnold Schwarzenegger weeks after he doubled down on his bold Bitcoin (CRYPTO: BTC) forecast. From Pumping Iron To Pumping Bitcoin On Monday, the SkyBridge Capital CEO joked that he was the Danny DeVito in a nod to the 1988 comedy "Twins" while sharing a video with Schwarzenegger on X, formerly Twitter. "We are Twins. ...

Core Insights - Elevated interest rates and high home prices are squeezing American homebuyers' budgets, leading to predictions of skyrocketing rental rates and home prices over the next decade [2][5] - The real estate market is shifting towards a rental-centric model, with predictions that Americans will increasingly rent various aspects of their lives, including homes and cars [4][5] - Strategies for investing in real estate without substantial debt include using crowdfunding platforms, as many prospective buyers feel priced out of the market due to high mortgage rates [6][5] Economic Context - As of August 2025, the Consumer Price Index for All Urban Consumers increased by 2.9% compared to the previous year, indicating ongoing inflationary pressures [1] - The average 30-year fixed mortgage rate is around 6.5% in 2025, marking the highest levels since 2002 [6] Future Predictions - Grant Cardone forecasts a significant shift in mortgage terms, suggesting that longer mortgage durations (up to 100 years) may become common in the future as a response to high prices [7]

Core Insights - Regeneron Pharmaceuticals has received FDA approval for a label extension of its cholesterol drug Evkeeza for children aged one to less than five years with homozygous familial hypercholesterolemia (HoFH) [1][7] - The approval is based on clinical efficacy and safety data from six children with HoFH [2][7] - Evkeeza generated sales of $72.1 million in the U.S. during the first half of 2025 [3][7] Drug Development and Commercialization - Evkeeza was initially approved in 2021 for adults and adolescents aged 12 years and older with HoFH, followed by approval for children aged five to 11 years [2] - Regeneron is responsible for the development and distribution of Evkeeza in the U.S., while Ultragenyx Pharmaceutical is responsible for commercialization outside the U.S. [4][7] Financial Performance - Eylea, Regeneron's lead drug, has faced declining sales due to competition from Roche's Vabysmo, impacting the company's overall revenue [5][6] - Eylea HD sales surged 29% in the second quarter due to increased demand [9] Portfolio Diversification - Regeneron is working to diversify its portfolio, with solid sales from Dupixent contributing to its top line [10] - Recent progress in the oncology portfolio, including Libtayo and Lynozyfic, is expected to enhance growth [11]